| Expression of human apolipoprotein E3 or E4 in the brains ofApoE−/− mice: Isoform-specific effects on neurodegeneration M Buttini, M Orth, S Bellosta, H Akeefe, RE Pitas, T Wyss-Coray, L Mucke, ... Journal of Neuroscience 19 (12), 4867-4880, 1999 | 459 | 1999 |
| Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females J Raber, D Wong, M Buttini, M Orth, S Bellosta, RE Pitas, RW Mahley, ... Proceedings of the National Academy of Sciences 95 (18), 10914-10919, 1998 | 440 | 1998 |
| Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth S Bellosta, BP Nathan, M Orth, LM Dong, RW Mahley, RE Pitas Journal of Biological Chemistry 270 (45), 27063-27071, 1995 | 377 | 1995 |
| Cholesterol: its regulation and role in central nervous system disorders M Orth, S Bellosta Cholesterol 2012 (1), 292598, 2012 | 349 | 2012 |
| Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n− 3 fatty acids S Westphal, M Orth, A Ambrosch, K Osmundsen, C Luley The American journal of clinical nutrition 71 (4), 914-920, 2000 | 244 | 2000 |
| Gangliosides in normal human serum: concentration, pattern and transport by lipoproteins HJ SENN, M Orth, E Fitzke, H Wieland, W Gerok European Journal of Biochemistry 181 (3), 657-662, 1989 | 188 | 1989 |
| The use of error and uncertainty methods in the medical laboratory WP Oosterhuis, H Bayat, D Armbruster, A Coskun, KP Freeman, A Kallner, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (2), 209-219, 2018 | 102 | 2018 |
| Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy (‘4P medicine’) M Orth, M Averina, S Chatzipanagiotou, G Faure, A Haushofer, V Kusec, ... Journal of clinical pathology 72 (3), 191-197, 2019 | 71 | 2019 |
| Effects of a Frequent Apolipoprotein E Isoform, ApoE4Freiburg (Leu28→Pro), on Lipoproteins and the Prevalence of Coronary Artery Disease in Whites M Orth, W Weng, H Funke, A Steinmetz, G Assmann, M Nauck, J Dierkes, ... Arteriosclerosis, thrombosis, and vascular biology 19 (5), 1306-1315, 1999 | 61 | 1999 |
| Multi-center analytical evaluation of a novel automated tacrolimus immunoassay M Shipkova, M Vogeser, PA Ramos, AG Verstraete, M Orth, C Schneider, ... Clinical biochemistry 47 (12), 1069-1077, 2014 | 58 | 2014 |
| Autoverification of test results in the core clinical laboratory EW Randell, S Yenice, AAK Wamono, M Orth Clinical biochemistry 73, 11-25, 2019 | 40 | 2019 |
| Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine M Vogeser, M Shipkova, R Rigo-Bonnin, P Wallemacq, M Orth, ... Therapeutic Drug Monitoring 36 (5), 640-650, 2014 | 39 | 2014 |
| Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype M Orth, S Wahl, M Hanisch, I Friedrich, H Wieland, C Luley Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1303 (1), 22-30, 1996 | 37 | 1996 |
| Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring M Shipkova, DT Petrova, AE Rosler, M Orth, J Engelmayer, E Wieland, ... Therapeutic drug monitoring 36 (4), 433-441, 2014 | 33 | 2014 |
| Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability M Orth, C Luley, H Wieland Thrombosis research 79 (3), 297-305, 1995 | 29 | 1995 |
| The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease J Dierkes, E Bissé, M Nauck, M Orth, H Mayer, C Luley, H Wieland Walter de Gruyter 36 (7), 453-457, 1998 | 26 | 1998 |
| ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro … FJLA Vanstapel, M Orth, T Streichert, ED Capoluongo, WP Oosterhuis, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (4), 608-626, 2023 | 24 | 2023 |
| Implementation of the new EU IVD regulation–urgent initiatives are needed to avert impending crisis C Cobbaert, ED Capoluongo, FJLA Vanstapel, PMM Bossuyt, HP Bhattoa, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (1), 33-43, 2022 | 24 | 2022 |
| Human serum gangliosides in hypercholesterolemia, before and after extracorporeal elimination of LDL HJ Senn, M Orth, E Fitzke, W Köster, H Wieland, W Gerok Atherosclerosis 94 (2-3), 109-117, 1992 | 22 | 1992 |
| Quantitative laboratory results: normal or lognormal distribution? F Klawonn, G Hoffmann, M Orth Journal of Laboratory Medicine 44 (3), 143-150, 2020 | 16 | 2020 |
Stefano BellostaUniversità degli Studi di Milano在 unimi.it 的电子邮件经过验证
